Northeastern Ohio Animal Imaging Resource Center- NOAIRC
俄亥俄州东北部动物成像资源中心 - NOAIRC
基本信息
- 批准号:7122500
- 负责人:
- 金额:$ 66.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-01 至 2009-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): We propose to form the Northeastern Ohio Animal Imaging Resource Center (NOAIRC) to provide the many regional cancer researchers with state-of-the-art small animal, molecular and cellular imaging facilities and expertise. Systems will include a combined micro-X-ray computed tomography/SPECT system, a clinical SPECT system with pin-hole collimators, a high resolution micro-PET system, and 7T and 9.4T small animal MR imaging and spectroscopy systems. All are already on-site or ordered from recent grant awards and institutional sources. With an SAIRP award, we will acquire a bioluminescence/fluorescence imaging system to facilitate reporter gene methods and new opportunities in novel agents (e.g., quantum dots). We will also create small animal optical coherence tomography with color Doppler and microscopic OCT to promote in vivo spectroscopic methods and high spatial and temporal analysis of structure and function (e.g., perfusion).
Interdisciplinary backing for this project is unprecedented with financial and other commitments from three schools of Case Western Reserve University (Medicine, Engineering, Arts & Sciences), the University Hospitals of Cleveland, the Case Comprehensive Cancer Center, and the State of Ohio. In addition to core resources via nuclear imaging, MR imaging and spectroscopy, bioluminescence/fluorescence, and OCT, the NOAIRC will also provide an integrated environment with core facilities in quantitative image analysis and visualization, animal welfare/experiment preparation and novel imaging agents like functionalized liposomes or CEST agents. This latter core integrates with our radionuclide imaging capabilities, our ongoing biomolecular and nanoscale engineering for targeted therapeutics initiative, ongoing research in reporter genes, and a P20 In-vivo and Molecular Imaging Center planning grant to add strategic strength in molecular imaging. All of these will be within a single facility to promote cross-collaboration and interdisciplinary research.
This proposal brings together researchers in imaging with the many regional scientists who are studying cancer biology via small animal models and rapidly gaining an appreciation of the power of in vivo imaging. We aim to advance small animal imaging technology by developing new image acquisition and analysis methods, new methods in reporter genes and functionalized agents, and pharmacokinetic modeling. We will apply developments to experiments in cancer biology and therapy. Animal welfare/preparation research will focus on analysis of physiologic effects of anesthesia and developing new formulations that maintain the physiology to be measured, while providing state-of-the-art methods for blood sampling and monitoring. The NOAIRC will include a strong educational focus to create a long-range impact. It will invigorate strong Ph.D. programs in imaging already at Case. It will strengthen educational programs for basic and clinical scientists in cancer via integration with existing T32 and K12 grants and promote new horizons via K25 proposals. The result will be clinicians, scientists, and engineers trained for the next generation of conventional and molecular imaging techniques.
描述(由申请人提供):我们建议成立东北俄亥俄州动物成像资源中心(NOAIRC),为许多区域癌症研究人员提供最先进的小动物、分子和细胞成像设施和专业知识。系统将包括一个组合的微型X射线计算机断层扫描/SPECT系统,一个具有针孔准直器的临床SPECT系统,一个高分辨率微型PET系统,以及7 T和9.4T小动物MR成像和光谱系统。所有这些都已经在现场或从最近的赠款和机构来源订购。凭借SAIRP奖,我们将获得生物发光/荧光成像系统,以促进报告基因方法和新试剂的新机会(例如,量子点)。我们还将创建具有彩色多普勒和显微OCT的小动物光学相干断层扫描,以促进体内光谱方法和结构和功能的高空间和时间分析(例如,灌注)。
该项目的跨学科支持是前所未有的,来自凯斯西储大学(医学,工程,艺术与科学),克利夫兰大学医院,凯斯综合癌症中心和俄亥俄州的三所学校的财政和其他承诺。除了通过核成像,MR成像和光谱学,生物发光/荧光和OCT的核心资源外,NOAIRC还将提供一个集成环境,其中包括定量图像分析和可视化,动物福利/实验准备和新型成像剂(如功能化脂质体或CEST试剂)的核心设施。后者核心整合了我们的放射性核素成像能力,我们正在进行的生物分子和纳米级工程靶向治疗计划,正在进行的报告基因研究,以及P20体内和分子成像中心规划拨款,以增加分子成像的战略实力。所有这些都将在一个单一的设施,以促进交叉合作和跨学科的研究。
该提案将成像领域的研究人员与许多通过小动物模型研究癌症生物学的区域科学家聚集在一起,并迅速了解体内成像的力量。我们的目标是通过开发新的图像采集和分析方法,报告基因和功能化试剂的新方法以及药代动力学建模来推进小动物成像技术。我们将把发展应用到癌症生物学和治疗的实验中。动物福利/准备研究将侧重于分析麻醉的生理效应,并开发新的制剂,以保持待测量的生理学,同时提供最先进的血液采样和监测方法。NOAIRC将包括一个强有力的教育重点,以创造长期影响。它将激发强大的博士学位。已经在凯斯的成像程序中。它将通过整合现有的T32和K12赠款,加强癌症基础和临床科学家的教育计划,并通过K25提案促进新的视野。其结果将是临床医生、科学家和工程师接受下一代常规和分子成像技术的培训。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Integrated software environment based on COMKAT for analyzing tracer pharmacokinetics with molecular imaging.
- DOI:10.2967/jnumed.109.064824
- 发表时间:2010-01
- 期刊:
- 影响因子:0
- 作者:Fang YH;Asthana P;Salinas C;Huang HM;Muzic RF Jr
- 通讯作者:Muzic RF Jr
A modified fuzzy C-means classification method using a multiscale diffusion filtering scheme.
- DOI:10.1016/j.media.2008.06.014
- 发表时间:2009-04
- 期刊:
- 影响因子:10.9
- 作者:Wang H;Fei B
- 通讯作者:Fei B
Gaussian Weighted Projection for Visualization of Cardiac Calcification.
用于心脏钙化可视化的高斯加权投影。
- DOI:10.1117/12.772597
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Chen,Xiang;Li,Ke;Gilkeson,Robert;Fei,Baowei
- 通讯作者:Fei,Baowei
PARACEST MRI with improved temporal resolution.
- DOI:10.1002/mrm.21863
- 发表时间:2009-02
- 期刊:
- 影响因子:3.3
- 作者:Liu G;Ali MM;Yoo B;Griswold MA;Tkach JA;Pagel MD
- 通讯作者:Pagel MD
Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI.
- DOI:10.1021/mp900040u
- 发表时间:2009-09
- 期刊:
- 影响因子:4.9
- 作者:Ali MM;Yoo B;Pagel MD
- 通讯作者:Pagel MD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY L. DUERK其他文献
JEFFREY L. DUERK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY L. DUERK', 18)}}的其他基金
NEW FACULTY RECRUITMENT IMAGE-GUIDED CANCER THERAPEUTICS
新教师招聘 影像引导癌症治疗
- 批准号:
7856254 - 财政年份:2009
- 资助金额:
$ 66.49万 - 项目类别:
NEW FACULTY RECRUITMENT IMAGE-GUIDED CANCER THERAPEUTICS
新教师招聘 影像引导癌症治疗
- 批准号:
7935301 - 财政年份:2009
- 资助金额:
$ 66.49万 - 项目类别:
Northeastern Ohio Animal Imaging Resource Center- NOAIRC
俄亥俄州东北部动物成像资源中心 - NOAIRC
- 批准号:
6941357 - 财政年份:2004
- 资助金额:
$ 66.49万 - 项目类别:
Northeastern Ohio Animal Imaging Resource Center- NOAIRC
俄亥俄州东北部动物成像资源中心 - NOAIRC
- 批准号:
7275344 - 财政年份:2004
- 资助金额:
$ 66.49万 - 项目类别:
相似海外基金
Highly sensitive bioluminescence and fluorescence imaging system for large fields of view
用于大视场的高灵敏度生物发光和荧光成像系统
- 批准号:
520682693 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Major Research Instrumentation
A bioluminescent-based imaging probe for noninvasive longitudinal monitoring of CoQ10 uptake in vivo
基于生物发光的成像探针,用于体内 CoQ10 摄取的无创纵向监测
- 批准号:
10829717 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Orthogonal split luciferases for imaging multiplexed cellular behaviors
用于多重细胞行为成像的正交分裂荧光素酶
- 批准号:
10730660 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Disease-homing light delivery by engineering bioluminescent immune cells for whole body precision photomedicine
通过工程生物发光免疫细胞进行疾病引导光传输,用于全身精准光医学
- 批准号:
10578425 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Nanoluciferase reporter phage for rapid phenotypic characterization of resistance to next-generation antimycobacterial agents
纳米荧光素酶报告噬菌体用于快速表征下一代抗分枝杆菌药物的耐药性
- 批准号:
10593796 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Novel Bioprinted Neural Stem Cell-Embedded Hydrogel Matrices for Enhanced Treatment of Glioblastoma
新型生物打印神经干细胞嵌入水凝胶基质,用于增强胶质母细胞瘤的治疗
- 批准号:
10749330 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Project 2 - Molecular Imaging of ectopic calcification
项目 2 - 异位钙化的分子成像
- 批准号:
10628929 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
通过病毒特异性 T 细胞的原位编程使 CAR T 细胞疗法大众化
- 批准号:
10739646 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Optical platform for functional longitudinal imaging of metabolite uptake in vivo
用于体内代谢物摄取功能纵向成像的光学平台
- 批准号:
10585764 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别:
Synergistically Target Mitochondria for Heart Failure Treatment
协同靶向线粒体治疗心力衰竭
- 批准号:
10584938 - 财政年份:2023
- 资助金额:
$ 66.49万 - 项目类别: